Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Leases Current Taxes Dividends payables Finished Goods Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

Envoy Medical (COCH) Notes Payables (2022 - 2023)

Envoy Medical's Notes Payables history spans 2 years, with the latest figure at $4.0 million for Q3 2023.

On a quarterly basis, Notes Payables changed N/A to $4.0 million in Q3 2023 year-over-year; TTM through Sep 2023 was $4.0 million, a N/A change, with the full-year FY2022 number at $448000.0, changed N/A from a year prior.
Notes Payables hit $4.0 million in Q3 2023 for Envoy Medical, up from $448000.0 in the prior quarter.
Over the last five years, Notes Payables for COCH hit a ceiling of $4.0 million in Q3 2023 and a floor of $448000.0 in Q4 2022.